Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Emma Rose 2025 Nov 15, 00:00

US Stock Market Outlook: Jitters and Potential Catalysts

Ava Grace 2025 Nov 15, 00:00

Fiscal Firefighting: US & Japan's Unorthodox Inflation Strategy

Sophia Claire 2025 Nov 15, 00:00

Guggenheim Partners Sees Fed Rate Cut in December Amid Economic Slowdown Concerns

Ava Grace 2025 Nov 15, 00:00

US Government Shutdown Aftermath: Rate Cut Concerns and Market Uncertainty

Sophia Claire 2025 Nov 15, 00:00

El-Erian Flags Economic Worries: Low-Income Consumers & Debt Refinancing

Frances Wang 2025 Nov 13, 16:00

Commodity market today: Gold prices are rising, what is XAU/USD prediction?

Frances Wang 2025 Nov 13, 16:00

AI stocks are trending: Qualcomm stock, Nvidia (NVDA), AMD stock

Ghko B 2025 Nov 12, 16:00

VOO performance analysis: What is the VOO ETF performance prediction?

Ghko B 2025 Nov 12, 16:00

Easy stocks for beginners: MSFT stock, AAPL stock, NVIDIA (NASDAQ: NVDA)

Frances Wang 2025 Nov 12, 16:00

Stellar climbs 4% today: Stellar (XLM) Price Prediction for 2025, 2026, 2030

Latest news

Show more
Noah Lee 2025 Nov 17, 02:51

Weekly Blockchain Funding Report: 10 Deals Surpass $195 Million

Liam James 2025 Nov 17, 02:50

Aster's Multi-Track Incentive Strategy Fuels Decentralized Exchange Growth

Liam James 2025 Nov 17, 02:40

Crypto Market Analysis: Filecoin, ZEC, BTC, ETH, and Token Unlocks

Ava Grace 2025 Nov 17, 02:00

Harvard Boosts Bitcoin ETF Investment by Over 250% in Q3

Emma Rose 2025 Nov 17, 01:50

Cardano Holder Loses Millions in Illiquid Stablecoin Swap

Ava Grace 2025 Nov 17, 01:40

25 Brutal Truths About Trading No One Tells You

Noah Lee 2025 Nov 17, 00:40

JPEX Collapse: Hong Kong's Biggest Crypto Fraud Exposes Risks of Unlicensed Platforms

Noah Lee 2025 Nov 16, 23:50

Bitcoin Price Volatility in 2025: Market Analysis and Future Outlook

Info

Spread

0.29

Spread (%)

0.6235 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

98998673408

Shares Outstanding

2035753027

Earnings Date (Next)

2001-08-07

Div Yield

2025-11-03

Ex-Dividend Date

2025-10-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0532

EPS

2.97

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 13, 16:00

Which broker is best for bitcoin trading: Cheapest Ways to Buy Bitcoin In 2026

Ghko B 2025 Nov 13, 16:00

Crypto day trading strategy: How to day trade crypto as a beginner?

Ghko B 2025 Nov 13, 16:00

Commodity trading strategy: WTI Oil faces potential decline, what’s next?

Trustpilot